INVITED COMMENTARY

A health care ecosystem is evolving in which all stakeholders will need to work together, apply new technologies, and use disparate data sources to gain insights, increase efficiencies, and improve patient outcomes. The pharmaceutical industry is leveraging its experience and analytics capabilities to play an important role in this evolution. For more than 60 years, the pharmaceutical industry has focused on research into data-driven care—a process that is fundamental in drug development and has seemingly remained unchanged [1]. Scientists within industry con-tinue to work alongside those in academia, government, and clinical practice to study factors that play important roles in biological function, disease progression, and the mecha-nisms of action of potential medical interventions. This work has produced terabytes of information about genetics and molecular biology to further our understanding of disease